Table of Contents Author Guidelines Submit a Manuscript
International Journal of Dentistry
Volume 2014, Article ID 452737, 7 pages
http://dx.doi.org/10.1155/2014/452737
Review Article

Is Bisphosphonate-Related Osteonecrosis of the Jaw an Infection? A Histological and Microbiological Ten-Year Summary

1University of Arkansas for Medical Sciences (UAMS), College of Medicine, Little Rock, AR 72205, USA
2Department of Otorhinolaryngology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA
3Department of Biostatistics, UAMS, Little Rock, AR 72205, USA
4Department of Otolaryngology-Head and Neck Surgery, UAMS, 4301 W. Markham Street No. 543, Little Rock, AR 72205, USA

Received 10 March 2014; Accepted 26 May 2014; Published 24 June 2014

Academic Editor: Giuliano Ascani

Copyright © 2014 A. M. Hinson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Jacobsen, W. Zemann, J. A. Obwegeser, K. W. Grätz, and P. Metzler, “The phosphorous necrosis of the jaws and what can we learn from the past: a comparison of “phossy” and “bisphossy” jaw,” Oral and Maxillofacial Surgery, pp. 1–7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. R. E. Marx, “Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic,” Journal of Oral and Maxillofacial Surgery, vol. 61, no. 9, pp. 1115–1117, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Malan, K. Ettinger, E. Naumann, and O. R. Beirne, “The relationship of denosumab pharmacology and osteonecrosis of the jaws,” Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol. 114, no. 6, pp. 671–676, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. J.-Y. Ohe, Y.-D. Kwon, and H.-W. Lee, “Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts,” Clinical Oral Investigations, vol. 16, no. 4, pp. 1153–1159, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. S. T. Sonis, B. A. Watkins, G. D. Lyng, M. A. Lerman, and K. C. Anderson, “Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients,” Oral Oncology, vol. 45, no. 2, pp. 164–172, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. R. H. Kim, R. S. Lee, D. Williams et al., “Bisphosphonates induce senescence in normal human oral keratinocytes,” Journal of Dental Research, vol. 90, no. 6, pp. 810–816, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Pautke, K. Kreutzer, J. Weitz, M. Knölder, D. Münzel et al., “Bisphosphonate related osteonecrosis of the jaw: a mini-pig large animal model,” Bone, vol. 51, pp. 592–599, 2012. View at Google Scholar
  8. M. R. Allen, “Studying the role of microcracks in the pathophysiology of BRONJ,” Clinical Oral Investigations, vol. 13, no. 4, pp. 481–482, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Pigrau-Serrallach, E. Cabral-Galeano, B. Almirante-Gragera et al., “Long-term follow-up of jaw osteomyelitis associated with bisphosphonate use in a tertiary-care center,” Enfermedades Infecciosas y Microbiologia Clinica, vol. 32, no. 1, pp. 18–22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Anavi-Lev, Y. Anavi, G. Chaushu, D. M. Alon, G. Gal, and I. Kaplan, “Bisphosphonate related osteonecrosis of the jaws: clinico-pathological investigation and histomorphometric analysis,” Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol. 115, no. 5, pp. 660–666, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Belcher, J. Boyette, T. Pierson et al., “What is the role of positron emission tomography in osteonecrosis of the jaws?” Journal of Oral and Maxillofacial Surgery, vol. 72, no. 2, pp. 306–310, 2014. View at Publisher · View at Google Scholar
  12. X. Wei, S. Pushalkar, C. Estilo et al., “Molecular profiling of oral microbiota in jawbone samples of bisphosphonate-related osteonecrosis of the jaw,” Oral Diseases, vol. 18, no. 6, pp. 602–612, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Favia, G. P. Pilolli, and E. Maiorano, “Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laser scanning microscopy,” Bone, vol. 45, no. 3, pp. 406–413, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. L. Paparella, D. Brandizzi, E. Santini-Araujo, and R. L. Cabrini, “Histopathological features of osteonecrosis of the jaw associated with bisphosphonates,” Histopathology, vol. 60, no. 3, pp. 514–516, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Tsurushima, S. Kokuryo, O. Sakaguchi, J. Tanaka, and K. Tominaga, “Bacterial promotion of bisphosphonate-induced osteonecrosis in Wistar rats,” International Journal of Oral and Maxillofacial Surgery, vol. 42, no. 11, pp. 1481–1487, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. N. H. Naik and T. A. Russo, “Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces,” Clinical Infectious Diseases, vol. 49, no. 11, pp. 1729–1732, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Schipmann, P. Metzler, M. Rossle, W. Zemann, J. V. Jackowski et al., “Osteopathology associated with bone resorption inhibitors—which role does Actinomyces play? A presentation of 51 cases with systematic review of the literature,” Journal of Oral Pathology & Medicine, vol. 42, no. 8, pp. 587–593, 2013. View at Publisher · View at Google Scholar
  18. I. Kaplan, K. Anavi, Y. Anavi et al., “Clinico-pathologic analysis of Actinomyces-associated lesions of the oral cavity and jaw bones,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 103, no. 6, p. 790, 2007. View at Publisher · View at Google Scholar
  19. I. Kaplan, K. Anavi, Y. Anavi et al., “The clinical spectrum of Actinomyces-associated lesions of the oral mucosa and jawbones: correlations with histomorphometric analysis,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 108, no. 5, pp. 738–746, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Ganguli, C. Steward, S. L. Butler et al., “Bacterial adhesion to bisphosphonate coated hydroxyapatite,” Journal of Materials Science: Materials in Medicine, vol. 16, no. 4, pp. 283–287, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Kos, A. Junka, D. Smutnicka, M. Bartoszewicz, T. Kurzynowski, and K. Gluza, “Pamidronate enhances bacterial adhesion to bone hydroxyapatite. Another puzzle in the pathology of bisphosphonate-related osteonecrosis of the jaw?” Journal of Oral and Maxillofacial Surgery, vol. 71, no. 6, pp. 1010–1016, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Mawardi, G. Giro, M. Kajiya et al., “A role of oral bacteria in bisphosphonate-induced osteonecrosis of the jaw,” Journal of Dental Research, vol. 90, no. 11, pp. 1339–1345, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. P. P. Sedghizadeh, S. Yooseph, D. W. Fadrosh et al., “Metagenomic investigation of microbes and viruses in patients with jaw osteonecrosis associated with bisphosphonate therapy,” Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol. 114, no. 6, pp. 764–770, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. S. K. Kumar, A. Gorur, C. Schaudinn, C. F. Shuler, J. W. Costerton, and P. P. Sedghizadeh, “The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy,” Current Osteoporosis Reports, vol. 8, no. 1, pp. 40–48, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. B. M. Durie, M. Katz, and J. Crowley, “Osteonecrosis of the jaw and bisphosphonates,” The New England Journal of Medicine, vol. 353, no. 1, pp. 99–102, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. V. Thumbigere-Math, L. Tu, S. Huckabay et al., “A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates,” The American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 35, no. 4, pp. 386–392, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. W. E. Shankland, “Evaluation of the oral flora in 150 patients suffering from chronic craniofacial pain: a retrospective study,” Orofacial Pain, vol. 28, no. 2, pp. 97–104, 2010. View at Google Scholar · View at Scopus
  28. B. M. Clarke, J. Boyette, E. Vural, J. Y. Suen, E. J. Anaissie, and B. C. Stack Jr., “Bisphosphonates and jaw osteonecrosis: the UAMS experience,” Otolaryngology—Head and Neck Surgery, vol. 136, no. 3, pp. 396–400, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Hoefert and H. Eufinger, “Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw,” Journal of Oral and Maxillofacial Surgery, vol. 69, no. 2, pp. 362–380, 2011. View at Publisher · View at Google Scholar · View at Scopus